Rafael Holdings RFL
NYSE RFL
$2.29 -0.14 (-5.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) FCF Margin (2017 - 2026)

Rafael Holdings' (RFL) quarterly FCF Margin came in at 4069.27% in Q2 2026, down 318833.0% year-over-year from N/an in Q2 2025, and down 14.13% quarter-over-quarter from 3565.4% in Q1 2026.

Analysis

Rafael Holdings (RFL) FCF Margin (2017 - 2026) Analysis & Trends

Rafael Holdings (RFL) has reported FCF Margin for 10 consecutive years, with 4069.27% the latest figure, recorded in Q2 2026.

  • On a quarterly basis, FCF Margin fell 318833.0% year-over-year to 4069.27% in Q2 2026; TTM through Apr 2026 was 3264.18%, a 170121.0% decrease from a year earlier, with the FY2025 full-year figure at 2064.12%, up 6351.0% from the prior year.
  • FCF Margin was 4069.27% for Q2 2026 at Rafael Holdings, down from 3565.4% in the prior quarter.
  • Over five years, FCF Margin peaked at 880.94% in Q2 2025 and troughed at 13638.16% in Q2 2022.
  • A 5-year average of 3997.44% and a median of 2985.53% in 2025 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin plunged 1332250 bps in 2022 and jumped 1178745 bps in 2023, its largest moves.
  • Over 5 years, FCF Margin stood at 3685.71% in 2022, then grew by 15 bps to 3136.76% in 2023, then climbed by 24 bps to 2381.25% in 2024, then declined by 19 bps to 2835.83% in 2025, then slumped by 43 bps to 4069.27% in 2026.
  • The last three FCF Margin figures came in at 4069.27% (Q2 2026), 3565.4% (Q1 2026), and 2835.83% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 34.70%
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 44.00%
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 30.39%
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 13.35%
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -388.28%
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 22.62%
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 14.91%
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -18,629.40%
10 Rafael Holdings 117.57 Mn 117.57 Mn 171,000.00 -4,069.27%
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -4,069.27%
Jan 31, 2026 -3,565.40%
Oct 31, 2025 -2,835.83%
Jul 31, 2025 -2,964.57%
Apr 30, 2025 -880.94%
Jan 31, 2025 -3,006.49%
Oct 31, 2024 -2,381.25%
Jul 31, 2024 -1,750.91%
Apr 30, 2024 -1,783.04%
Jan 31, 2024 -3,719.12%
Oct 31, 2023 -3,136.76%
Jul 31, 2023 -2,129.41%
Apr 30, 2023 -1,850.70%
Jan 31, 2023 -7,920.00%
Oct 31, 2022 -3,685.71%
Jul 31, 2022 -2,757.97%
Apr 30, 2022 -13,638.16%
Jan 31, 2022 -9,878.38%
Oct 31, 2021 -3,404.71%
Jul 31, 2021 315.91%